Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study

Jennifer H. Hayes, Kristin E. Anderson and Aaron R. Folsom
Jennifer H. Hayes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin E. Anderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron R. Folsom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-06-0172 Published November 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    Characteristics of women who developed lung cancer and noncases in the IWHS

    CharacteristicsAll lung cancer cases, N = 403, n (%)Noncases, N = 26,759, n (%)HR (95% CI)P
    Age
        61-65148 (36.7)9,974 (37.3)1.00 (reference)
        66-70142 (35.2)9,392 (35.1)1.02 (0.81-1.28)
        71+113 (28.0)7,383 (27.6)1.03 (0.80-1.32)0.97
    Pack-years
        073 (18.8)18,174 (69.4)1.00 (reference)
        1-1923 (5.9)3,537 (13.5)1.62 (1.01-2.59)
        20-39122 (31.4)2,665 (10.2)11.4 (8.50-15.3)
        40+170 (43.8)1,808 (6.9)23.4 (17.7-30.9)<0.0001
    Smoking status
        Never73 (18.5)18,174 (69.0)1.00 (reference)
        Past148 (37.5)6,008 (22.8)6.13 (4.63-8.13)
        Current174 (44.0)2,178 (8.3)19.9 (15.1-26.2)<0.0001
    Alcohol (g/d)
        0175 (43.4)14,963 (55.9)1.00 (reference)
        0.9-1.954 (13.4)3,974 (14.8)1.16 (0.85-1.56)
        ≥2174 (43.2)7,822 (29.2)1.90 (1.52-2.32)<0.0001
    Education
        <High school graduate91 (22.6)4,603 (17.2)1.00 (reference)
        High school graduate164 (40.7)11,308 (42.4)0.73 (0.57-0.95)
        Post-high school148 (36.7)10,791 (40.4)0.69 (0.53-0.90)0.02
    BMI
        ≥30 kg/m257 (14.1)6,085 (22.7)0.56 (0.42-0.74)<0.0001
    WHR
        ≥0.8274 (median)203 (50.6)13,338 (50.0)1.03 (0.84-1.25)0.80
    Total fruit servings weekly
        ≥17 (median)149 (37.0)13,486 (50.4)0.58 (0.47-0.71)<0.0001
    Total vegetable servings weekly
        ≥22.5 (median)194 (48.1)13,764 (51.4)0.88 (0.72-1.07)0.19
    Energy intake (kcal/d)
        ≥1707 (median)205 (50.9)13,383 (50.0)1.03 (0.85-1.26)0.73
    Current vitamin use117 (29.1)8,763 (33.2)0.84 (0.68-1.04)0.03
    History of arthritis206 (51.8)12,749 (48.2)0.87 (0.71-1.06)0.16
    History of high blood pressure136 (34.4)9,450 (36.1)1.16 (0.87-1.54)0.49
    History of migraines40 (10.0)2,544 (9.6)1.04 (0.75-1.45)0.95
    Family history of cancer159 (39.4)10,013 (37.5)1.09 (0.89-1.33)0.40
    History of heart disease/heart attack75 (21.1)3,297,(14.1)1.74 (1.35-2.25)0.0002
    • NOTE: Baseline (1986) variables: BMI, WHR, family history of lung cancer, family history of cancer, pack-years, high blood pressure, multivitamin use, fruit and vegetable intake, education, and energy intake. Follow-up (1992) variables: age, history of arthritis, smoking status, history of heart disease/heart attack, history of migraines, and alcohol.

  • Table 2.

    Prevalence (%) of participant characteristics by frequency of aspirin or other NSAID use

    CharacteristicsAspirin*
    NSAIDS*
    0
    <1
    1
    2-5
    6+
    0
    <1
    1
    2-5
    6+
    n = 7,628n = 7,524n = 1,492n = 4,799n = 5,719n = 16,429n = 4,158n = 836n = 2,182n = 3,557
    Age, >65 y†65596462666458636063
    BMI, ≥30 kg/m2‡25192021252021242634
    WHR, ≥0.8274‡52465048544947515056
    Multivitamin use‡31303434373133363737
    Currently smoking†988910988910
    History of migraines†9781113810101314
    History of arthritis‡53444652634451586479
    History of high blood pressure‡36303336443433373743
    History of heart disease/heart attack†138912271412141418
    High school graduate or higher education‡82868282828385808182
    Alcohol, ≥2 g/d†26303233292833353228
    • NOTE: Tests of overall difference in characteristics among NSAID categories were all significant, except BMI by aspirin (P = 0.51) and alcohol by both aspirin (P = 0.16) and NSAID use (P = 0.16).

    • ↵* Frequency of use (weekly).

    • ↵† 1992.

    • ↵‡ 1986.

  • Table 3.

    Association of aspirin or non-aspirin NSAID use with lung cancer incidence, IWHS, 1992-2002

    No. casesTotal person-yearsAge-adjusted HR* (95% CI)Multivariate-adjusted HR*† (95% CI)Multivariate-adjusted HR*‡ (95% CI)
    Aspirin use
        Never11073,6581.001.001.00 (1.00)
        ≤1 weekly12689,7670.96 (0.74-1.25)1.10 (0.84-1.43)1.01 (0.77-1.35)
        2-5 weekly5847,6150.83 (0.60-1.14)0.87 (0.63-1.21)0.85 (0.60-1.19)
        6+ weekly10955,0461.34 (1.02-1.74)1.21 (0.92-1.59)1.08 (0.81-1.45)
    Ptrend0.010.220.58
    NSAID use
        Never241160,6231.001.001.00
        ≤1 weekly6849,6520.93 (0.71-1.22)0.99 (0.75-1.30)0.92 (0.68-1.24)
        2-5 weekly3321,5031.04 (0.72-1.50)1.10 (0.76-1.60)1.16 (0.79-1.70)
        6+ weekly6134,3081.16 (0.88-1.54)1.23 (0.92-1.65)1.10 (0.80-1.51)
    Ptrend0.640.530.71
    • ↵* Aspirin analyses adjusted for NSAID use and NSAID analyses adjusted for aspirin use.

    • ↵† Adjusted for age (61-65, 66-70, and 71+), education (<high school, high school, and >high school), alcohol intake (continuous), smoking status (never, past, and current), pack-years (0, 1-19, 20-39, and 40+), BMI (continuous), and total fruit servings weekly (continuous).

    • ↵‡ Adjusted for age (61-65, 66-70, and 71+), education (<high school, high school, and >high school), alcohol intake (continuous), smoking status (never, past, and current), pack-years (0, 1-19, 20-39, and 40+), BMI (continuous), total fruit servings weekly (continuous), and history of heart disease/heart attack (yes and no).

  • Table 4.

    Joint association of aspirin and NSAID use with lung cancer incidence, IWHS, 1992-2002

    Aspirin use*
    Other NSAID useHR (95% CI)Nonusers<1-5 weekly6+ weekly
    Nonusers1 (referent)1.03 (0.74-1.44)1.19 (0.82-1.73)
    <1-5 weekly1.09 (0.65-1.82)1.02 (0.69-1.51)1.14 (0.67-1.92)
    6+ weekly1.36 (0.82-2.26)1.00 (0.54-1.83)1.23 (0.67-2.26)
    • NOTE: Adjusted for age (61-65, 66-70, and 71+ years), education (<high school, high school, and >high school), alcohol intake (continuous), smoking status (never, past, and current), pack-years (0, 1-19, 20-39, and 40+), BMI (continuous), total fruit servings weekly (continuous), and any heart disease/heart attack.

    • ↵* Aspirin analyses adjusted for NSAID use and NSAID analyses adjusted for aspirin use.

  • Table 5.

    Association of aspirin and NSAID use and incident lung cancer by pack-years of smoking, IWHS, 1992-2002

    Pack-years
    0
    <40
    40+
    n = 73 cases; n = 18,134 noncases
    n = 144 cases; n = 6,161 noncases
    n = 169 cases; n = 1,798 noncases
    Adjusted HR (95% CI)Adjusted HR (95% CI)Adjusted HR (95% CI)
    Aspirin use
        Never1.001.001.00
        ≤1 weekly1.06 (0.58-1.95)0.87 (0.55-1.35)1.14 (0.73-1.80)
        2-5 weekly0.97 (0.47-2.02)0.76 (0.44-1.32)0.89 (0.51-1.54)
        6+ weekly0.71 (0.33-1.54)1.06 (0.66-1.68)1.34 (0.86-2.08)
    Ptrend0.770.660.41
    NSAID use
        Never1.001.001.00
        ≤1 weekly0.85 (0.42-1.72)0.96 (0.61-1.52)0.92 (0.57-1.47)
        2-5 weekly1.57 (0.70-3.52)0.83 (0.42-1.66)1.25 (0.70-2.22)
        6+ weekly1.28 (0.61-2.66)0.91 (0.53-1.56)1.18 (0.73-1.88)
    Ptrend0.590.950.74
    • NOTE: Adjusted for age (61-65, 66-70, and 71+ years), education (<high school, high school, and >high school), alcohol intake (continuous), BMI (continuous), total fruit servings weekly (continuous), and any heart disease/heart attack (yes and no). Aspirin analyses adjusted for NSAID use and NSAID analyses adjusted for aspirin use.

  • Table 6.

    Association of aspirin or NSAID use with incident lung cancer by histologic type, IWHS, 1992-2002

    Histologic type
    Small cell
    Squamous
    Adenocarcinoma
    Other
    n = 65 cases; n = 26,414 noncases
    n = 73 cases; n = 26,406 noncases
    n = 142 cases; n = 26,357 noncases
    n = 106 cases; n = 26,353 noncases
    Adjusted HR (95% CI)Adjusted HR (95% CI)Adjusted HR (95% CI)Adjusted HR (CI 95%)
    Aspirin use
        Never1.001.001.001.00
        ≤1 weekly1.46 (0.70-3.06)0.60 (0.28-1.29)1.24 (0.77-2.01)1.049 (0.68-1.61)
        2-5 weekly1.34 (0.58-3.13)1.18 (0.57-2.45)0.80 (0.43-1.50)0.68 (0.38-1.19)
        6+ weekly1.46 (0.68-3.13)1.31 (0.68-2.51)1.50 (0.92-2.45)0.64 (0.38-1.07)
    Ptrend0.740.210.160.14
    NSAID use
        Never1.001.001.001.00
        ≤1 weekly0.92 (0.45-1.85)1.24 (0.64-2.40)1.05 (0.66-1.60)0.62 (0.36-1.08)
        2-5 weekly0.63 (0.19-2.06)1.80 (0.83-3.91)1.26 (0.66-2.39)1.00 (0.52-1.93)
        6+ weekly0.94 (0.41-2.12)0.91 (0.40-2.06)1.13 (0.65-1.95)1.32 (0.82-2.14)
    Ptrend0.900.450.890.17
    • NOTE: Adjusted for age (61-65, 66-70, and 71+ years), education (<high school, high school, and >high school), alcohol intake (continuous), smoking status (never, past, and current), pack-years (0, 1-19, 20-39, and 40+), BMI (continuous), total fruit servings weekly (continuous), and any heart disease/heart attack (yes and no).

      Aspirin analyses adjusted for NSAID use and NSAID analyses adjusted for aspirin use.

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 15 (11)
November 2006
Volume 15, Issue 11
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study
Jennifer H. Hayes, Kristin E. Anderson and Aaron R. Folsom
Cancer Epidemiol Biomarkers Prev November 1 2006 (15) (11) 2226-2231; DOI: 10.1158/1055-9965.EPI-06-0172

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study
Jennifer H. Hayes, Kristin E. Anderson and Aaron R. Folsom
Cancer Epidemiol Biomarkers Prev November 1 2006 (15) (11) 2226-2231; DOI: 10.1158/1055-9965.EPI-06-0172
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Gallstones and Gallbladder Cancer
  • Additive Effects of Aristolochic Acid and Arsenic in UTUC
  • Provider Lifestyle Discussions
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement